Showing results (71-80 of 365) with videos related to
Sort By:
Pageof 37
Immunotargets and Therapy|June 18, 2026
Irinotecan Modulates Immune Checkpoints in NeuroblastomaTom Lapidus, Elina Zorde-Khvalevsky, Alaa Jolani, et al.Immunotargets and Therapy|May 4, 2026
RNA Sequencing Analyses and Validation of Immune-Related Genes in EBV-Specific Cytotoxic T Lymphocytes During Latent InfectionZhen Guan, Xiulan Ao, Lili Zhou, et al.Immunotargets and Therapy|August 8, 2026
Prognostic and Predictive Value of Peripheral CD8/PD-1/TCF-1 Positive T Cells in Non-Small Cell Lung Carcinoma PatientsAnastasia Xagara, Maria Goulielmaki, Evangelia Chantzara, et al.Immunotargets and Therapy|August 26, 2026
Longitudinal B Cell Receptor Repertoire Profiling of Heavy- and Light-Chain Features in Injured Rat Spinal Cord Tissue After Traumatic Spinal Cord InjuryTaotao Lin, Chao Qin, Ruixiong Du, et al.Immunotargets and Therapy|August 25, 2026
Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional StudyHiroshi Yokouchi, Hiroshi Nishihara, Yoshiyuki Kenmotsu, et al.Immunotargets and Therapy|September 20, 2026
A Myeloid-Specific Endogenous TRP1-CAR Knock-in Mouse Model for Melanoma-Targeted ImmunotherapyYuxin Hao, Xin Chen, Min Wang, et al.Immunotargets and Therapy|July 15, 2021
Targeting CD22 for the Treatment of B-Cell MalignanciesNikesh N Shah, Lubomir SokolImmunotargets and Therapy|July 8, 2021
CD38-Directed Therapies for Management of Multiple MyelomaHamza Hashmi, Muhammad Husnain, Ali Khan, et al.Immunotargets and Therapy|April 17, 2024
Correlation Between C4/IgG with Macroproteinuria in Chronic Kidney Disease: A Pilot StudyHao Zhang, Anqi Xu, Xiangxiang Li, et al.Immunotargets and Therapy|September 13, 2017
Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse eventsMarianne Davies, Emily A DuffieldPageof 37